Skip to main content

Table 2 Primary and secondary outcomes over the time

From: Efficacy of curcumin for amelioration of radiotherapy-induced oral mucositis: a preliminary randomized controlled clinical trial

Variables

Comparing

Curcumin Mouthwash

Curcumin capsule

Placebo Mouthwash

Between group P-Value

Mean Difference

Within group P-Value

Mean Difference

Within group P-Value

Mean Difference

Within group P-Value

WHO scale

W0

W1

0.385

0.018

0.33

0.20

0.36

0.100

0.981

W2

1.61

0.001

1.16

0.001

0.92

0.051

0.150

W3

2.23

0.001

1.70

0.001

0.72

0.070

0.002

W1

W2

1.23

0.001

0.83

0.001

0.54

0.052

0.074

W3

1.84

0.001

1.40

0.001

0.36

0.340

< 0.001

W2

W3

0.60

0.014

0.58

0.027

0.18

0.441

0.029

NRS

W0

W1

1.00

0.001

1.25

0.001

0.455

0.29

P < 0.01

W2

3.20

0.001

3.25

0.001

1.63

0.001

P < 0.01

W3

5.10

0.001

4.58

0.001

1.72

0.005

P < 0.01

W1

W2

2.23

0.001

2.00

0.001

1.18

0.019

P < 0.01

W3

4.10

0.001

3.33

0.001

1.27

0.002

P < 0.01

W2

W3

1.90

0.036

1.33

0.008

0.09

0.81

P < 0.01